Sign in
4

Changes in Ownership

PALISADE BIO, INC. Filed Acc 0001493152-23-032655

CEO, CFO, Director bought 15,000 shares at $0.66 ($9,825)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Finley John David CEO, CFO, Director 2023-09-13 Purchase +15,000 $0.66 $9,825 28,394 D: show line 1 in the form
Open-market purchases · 15,000 sh · avg $0.66 · $9,825
Loading xslF345X05/ownership.xml…